ENP110: Hypercortisolism and T2D

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. , is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. , is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at — for helpful links or to hear more podcast episodes, visit

You can listen to ENP110: Hypercortisolism and T2D online on Radio and Podcast. Open the player on this page to stream the available audio.

ENP110: Hypercortisolism and T2D is an episode from Endocrine News Podcast by Endocrine Society.

This episode is 20:03 long.

This episode was published on Jan 21, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Endocrine News Podcast when more episodes are available from the podcast feed.